CONMED
CNMD
264 hedge funds and large institutions have $3.27B invested in CONMED in 2019 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 90 increasing their positions, 96 reducing their positions, and 19 closing their positions.
184% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 19
172% more call options, than puts
Call options by funds: $2.8M | Put options by funds: $1.03M
17% more capital invested
Capital invested by funds: $2.8B → $3.27B (+$466M)
13% more funds holding
Funds holding: 234 → 264 (+30)
0.05% less ownership
Funds ownership: 103.06% → 103.01% (-0.05%)
6% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 96
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
Axa
Paris,
France
|
+$15.9M |
| 2 |
Man Group
London,
United Kingdom
|
+$14.6M |
| 3 |
Morgan Stanley
New York
|
+$13.2M |
| 4 |
HM
HealthCor Management
New York
|
+$11.6M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$10.7M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
276
Group One Trading
Chicago,
Illinois
| – | -$204K | -1,915 | Closed |
|
|
TRCT
277
Tower Research Capital (TRC)
New York
| – | -$84K | -873 | Closed |
|
|
MWNA
278
Marshall Wace North America
New York
| – | -$50K | -525 | Closed |
|
|
MCM
279
MV Capital Management
Bethesda,
Maryland
| – | -$7K | -71 | Closed |
|
|
CFA
280
Carroll Financial Associates
Charlotte,
North Carolina
| – | -$3K | -38 | Closed |
|
|
FRA
281
Front Row Advisors
Tiburon,
California
| – | -$4K | -37 | Closed |
|
|
TWA
282
TCI Wealth Advisors
Tucson,
Arizona
| – | -$2K | -25 | Closed |
|
|
EW
283
Evoke Wealth
Los Angeles,
California
| – | -$1.54K | -16 | Closed |
|
CNMD Hedge Fund Activity: Q4 2019 in Review
264 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q4 2019, worth a combined $3.27B — up 17% from $2.8B a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new CNMD positions and 19 closed out — a net gain of 35 holders — while 90 added to existing stakes and 96 trimmed.
The largest buyer was Axa, opening a new position worth an estimated $15.9M. The largest seller was Capital World Investors, cutting an estimated $37.3M.
- 264 institutional investors held CONMED (CNMD) as of Q4 2019, up from 234 in Q3 2019.
- Funds reported $3.27B of CONMED stock for Q4 2019, up 17% quarter-over-quarter.
- 54 funds opened new CONMED positions in Q4 2019 and 19 closed out, a net change of +35 holders.
- The largest CONMED buyer in Q4 2019 was Axa, an estimated $15.9M added.
- The largest CONMED seller in Q4 2019 was Capital World Investors, an estimated $37.3M sold.
Based on aggregated 13F filings for Q4 2019.